Why Choose Prolacta^®?

---

The Gold Standard
The American Academy of Pediatrics (AAP) adheres to the position that breastfeeding ensures the best possible health, as well as developmental and psychosocial, outcomes for the infant¹.

We are committed to world class and innovative products.
Prolacta Bioscience^® provides the first and only human milk formulations for use in the nutrition of very low birth weight (VLBW) and critically ill infants.

We are making a difference in the lives of premature infants.
Concern has been raised about the exposure to non-human protein sources and the infectious risks of powder-based fortifiers and formulas in the Neonatal Intensive Care Unit (NICU). Because of these concerns, Prolacta has developed a human-sourced, liquid fortifier (Prolact+ H²MF^™), which meets the American Dietetic Association (ADA) and Centers for Disease Control and Prevention (CDC) guidelines for the use of liquid feeding in the NICU.

As a science driven company, we are committed to improving premature infant nutrition through the use of human milk formulations in the NICU.

¹American Academy of Pediatrics: www.aap.org/breastfeeding